February 2016
Volume: 5  Issue :2
Visit our website at www.nepho.org
for more information, including: calendars, health plan information, fee schedules and more
2016 Quality Update
           NEW 2016 BCBS AQC Measures
Two new measures have been added to the BCBS AQC Quality Measure requirement for 2016.  Baseline data collected in 2015 suggests a need for review and education.  The new measures are:
  
1. Asthma Medication Ratio  (AMR)- Percentage of members 5-85 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the Quality Measurement Period.
  
WHY: To identify persistent asthmatics who are non-adherent with controller medications and/or those patients who may benefit from a long-term control medication (including patients w/Exercise Induced Bronchospasm)
  
WHO: Patients age 5-85 with persistent asthma, having at least 1 of the following criteria during both 2015 and 2016:    
  • 1 or more ED visits or acute IP encounters with principal dx asthma
  • 4 or more outpatient visits or observation visits with any diagnosis of asthma + 2 or more asthma medication dispensing events          
  • 4 or more asthma medication dispensing events
See the Asthma Medication Ratio (AMR) detail sheet for additional information on how the AMR is calculated. Asthma medication guidelines with relative costs for controllers and other asthma medications is also included.
  
2. Use of imaging studies in Low Back Pain- The percentage of patients with acute low back pain who did not have an imaging study, (plain x-ray, CT scan or MRI) within 28 days of the diagnosis of low back pain.
  
WHY: Low back pain is pervasive. Most common reason for visits to offices, outpatient departments and Emergency Rooms.
  • Imaging potentially can lead to unnecessary surgery and usually adds nothing to the course.
  • Most patients are back to their usual activities within 30 days and their course is unaffected by imaging. Pain usually improves within the first two weeks.
NEPHO Clinical Newsletter
Produced by Northeast Physician Hospital Organization
For more information contact: 
Carol Freedman, RPh, MAS, CGP 
Clinical Pharmacist NEPHO 
978-236-1774
cfreed@nhs-healthlink.org 
Louis Di Lillo M.D., Northeast PHO Medical Director 
In This Issue
BCBS AQC Quality measures are most important to NEPHO due to potential to earn significant quality dollars in 2016. Quality measures such as diabetes A1C testing and/or management and breast cancer / cervical cancer screening are evaluated by most commercial plans. 
  
In an effort to help practices keep track of the many quality measures for all NEPHO payers, a 2016 Quality All Payer Measure grid has been created. ACO (Medicare) quality measures are included on this grid.
The 2016 Recommended Adult Immunization  Schedule   was recently approved by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), the American College of Physicians (ACP), the American College of Obstetricians and Gynecologists (ACOG), and the American College of Nurse-Midwives (ACNM).  Click on the link for a copy.